Extendicare Inc. (OTCMKTS:EXETF – Get Free Report) shares shot up 0.1% during mid-day trading on Monday . The stock traded as high as $22.1193 and last traded at $22.1193. Approximately 668,325 shares were traded during trading, an increase of 1,021% from the average session volume of 59,636 shares. The stock had previously closed at $22.09.
Wall Street Analyst Weigh In
Several equities analysts have commented on the company. Canadian Imperial Bank of Commerce reaffirmed an “outperform” rating on shares of Extendicare in a report on Monday, August 10th. TD Securities reissued a “buy” rating on shares of Extendicare in a report on Monday, May 11th. Finally, Royal Bank Of Canada restated an “outperform” rating on shares of Extendicare in a research report on Friday, August 14th. Five research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy”.
Check Out Our Latest Stock Analysis on EXETF
Extendicare Price Performance
Extendicare Company Profile
Extendicare Inc (OTCMKTS:EXETF) is a Canada-based senior care provider headquartered in Markham, Ontario. The company specializes in the ownership and operation of long-term care homes, retirement residences and home health care services. It is publicly listed on the Toronto Stock Exchange under the symbol EXE and trades in the over-the-counter market as EXETF.
Extendicare’s operations are organized into two primary segments. The Long-Term Care & Retirement Living division operates approximately 120 facilities under the Extendicare and EspritVitalitĂ© banners, serving residents in Ontario, Alberta, Saskatchewan and parts of Atlantic Canada.
See Also
- Five stocks we like better than Extendicare
- Quantum Computing Is Raising the Stakes for Cybersecurity: 5 Stocks to Watch
- 5 Stocks to Buy in September Before Wall Street Catches On
- PDD Beat Earnings—So Why Did the Stock Still Fall?
- Tariffs Are Back in Focus: 3 Stocks With a Home-Field Advantage
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
